Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio Essence (BIOE) Operating Income (2020 - 2025)

Bio Essence has reported Operating Income over the past 6 years, most recently at $1.0 million for Q4 2025.

  • For Q4 2025, Operating Income rose 26629.67% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $900011.0, up 295.89%, while the annual FY2025 figure was $900011.0, 295.89% up from the prior year.
  • Operating Income for Q4 2025 was $1.0 million at Bio Essence, up from $14253.0 in the prior quarter.
  • Over five years, Operating Income peaked at $1.0 million in Q4 2025 and troughed at -$261295.0 in Q2 2021.
  • A 5-year average of -$63684.1 and a median of -$153861.5 in 2022 define the central range for Operating Income.
  • Biggest five-year swings in Operating Income: tumbled 524.55% in 2024 and later surged 26629.67% in 2025.
  • Year by year, Operating Income stood at -$198769.0 in 2021, then skyrocketed by 132.08% to $63759.0 in 2022, then crashed by 406.59% to -$195476.0 in 2023, then surged by 101.97% to $3852.0 in 2024, then surged by 26629.67% to $1.0 million in 2025.
  • Business Quant data shows Operating Income for BIOE at $1.0 million in Q4 2025, $14253.0 in Q3 2025, and $61223.0 in Q2 2025.